- Else Nutrition (BABY) will be presenting pre-clinical study results at the 9th International Conference on Nutrition & Growth
- The pre-clinical study is part of Else’s full clinical development program that provides exposure to Else scientific advances
- The conference will enable the exchange of ideas and knowledge between the different disciplines for facilitating research and clinical interdisciplinary collaborations
- Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products
- Else Nutrition Holdings Inc. (BABY) is up 5.98 per cent, trading at C$1.24 at 12:06 pm EST
Else Nutrition Holdings (BABY) will be a presenter at the 9th International Conference on Nutrition and Growth.
This conference will be held virtually between March 17 and 19, 2022.
Else Nutrition’s infant formula pre-clinical study will be presented as a part of the scientific program.
The conference brings together Pediatricians, Nutritionists, Neonatologists, experts in child development and other specialists to discuss the challenges of the interplay between Nutrition and Growth in the Pediatric age group.
The conference will enable the exchange of ideas and knowledge between the different disciplines for facilitating research and clinical interdisciplinary collaborations.
“This is a significant development for the Company, providing valuable exposure of our scientific advances, among leading experts in the field of child development,” said Hamutal Yitzhak, Else Nutrition CEO & Co-Founder.
N&G’s Organizing Committee members include world-class, key opinion leaders including Prof. Dominique Turck, Prof. Hans Van Goudoever, Prof. Moshe Phillip and Prof. Raanan Shamir.
All are Pediatricians (spanning Gastroenterologists, Endocrinologists, and Neonatologists) active in ESPGHAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition) and EFSA (European Food Safety Association).
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults.
Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan.
Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 top seller in the baby and toddler formula category on Amazon. It recently received the World Plant-Based Award for “Best dairy alternative product” in New York at World Plant-Based Expo in late 2021.
The holding company, Else Nutrition Holdings Inc., is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL.
Else Nutrition Holdings Inc. (BABY) is up 5.98 per cent, trading at C$1.24 at 12:06 pm EST.
